Risk-adapted preemptive therapy for cytomegalovirus disease after allogeneic stem cell transplantation: a single-center experience in Korea.
Choi
Su-Mi
SM
Lee
Dong-Gun
DG
Choi
Jung-Hyun
JH
Yoo
Jin-Hong
JH
Kim
Yoo-Jin
YJ
Park
Sun Hee
SH
Min
Chang-Ki
CK
Lee
Seok
S
Kim
Hee-Je
HJ
Kim
Dong-Wook
DW
Lee
Jong-Wook
JW
Min
Woo-Sung
WS
Shin
Wan-Shik
WS
Kim
Chun-Choo
CC
D000961:Antilymphocyte Serum / Q000008:administration & dosage; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D046148:Donor Selection; D005260:Female; D006801:Humans; D015994:Incidence; D007723:Korea; D019520:Living Donors; D008297:Male; D008991:Monitoring, Physiologic; D011446:Prospective Studies; D012307:Risk Factors; D033581:Stem Cell Transplantation / Q000009:adverse effects; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum